Intracameral phenylephrine to prevent floppy iris syndrome during cataract surgery in patients on tamsulosin
- 11 November 2005
- journal article
- Published by Springer Nature in Eye
- Vol. 21 (3) , 331-332
- https://doi.org/10.1038/sj.eye.6702172
Abstract
To describe the use of intracameral phenylephrine to prevent the floppy iris syndrome seen in patients who are on the drug tamsulosin for benign prostatic hypertrophy, during cataract surgery. Prince Charles Eye Unit, King Edward VII Hospital, Windsor, Berkshire, UK. Seven patients who were on systemic tamsulosin for benign prostatic hypertrophy received intracameral phenylephrine before capsulorexhis during their cataract surgery. There was a significant reduction in the amount of mobility of the iris, reduction in the expected fluttering, and sustained papillary dilatation. Intracameral phenylephrine is a simple and effective tool to prevent the effects of floppy iris syndrome in those patients undergoing cataract surgery who are on systemic tamsulosin.Keywords
This publication has 5 references indexed in Scilit:
- Intraoperative floppy iris syndrome associated with tamsulosinJournal of Cataract & Refractive Surgery, 2005
- Role of the newer alpha, -adrenergic-receptor antagonistsin the treatment of benign prostatic hyperplasia-related lower urinary tract symptomsClinical Therapeutics, 2004
- Comparison of various pupil dilatation methods for phacoemulsification in eyes with a small pupil secondary to pseudoexfoliationOphthalmology, 2004
- Intracameral mydriatics in phacoemulsification cataract surgeryJournal of Cataract & Refractive Surgery, 2003
- Efficiency of Pupillary Stretching in Cataract SurgeryEuropean Journal of Ophthalmology, 1998